When physician-industry interactions go awry

Financial connections between members of the profession and professional organizations and the pharmaceutical, device, and biotechnology industries are increasingly common and can lead to biased medical decision making, higher costs of care, and decline in the public’s trust of the profession. To preserve its reputation and its autonomy over medical decisions, the profession must begin to police itself.

Abbreviations:  FDA, US Food and Drug Administration